Want to Write a Research Protocol? What to Consider, Where to Start & How to Create a Protocol Draft

Want to Write a Research Protocol? What to Consider, Where to Start & How to Create a Protocol Draft
JoAnn Mick, PhD, RN, NEA-BC, Nurse Researcher, Memorial Hermann - Texas Medical Center

This presentation will provide information on the purpose and components of a research protocol and helpful strategies for writing a protocol draft with an Institutional Review Board reviewer’s perspective in mind. Three steps to writing an abstract, the difference between a study purpose and research question, and how to synthesize a review of literature that includes justification for conducting a study will be described. Other information will include: description of a critical thinking path for selecting appropriate data collection methodologies, describing risks and benefits to human subjects, and inclusion of a dissemination plan in study design.

Continuing Education Credit Hours:
SOCRA designates this educational activity for a maximum of 1 Continuing Education Credits for SOCRA CE and Nurse CNE. SOCRA designates this educational activity for a maximum of 1 AMA PRA Category 1 Credit(s)(TM). Physicians should claim credit commensurate with the extent of their participation in the activity.
Accreditation Statements:
CME for Physicians:
The Society of Clinical Research Associates is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
CNE for Nurses:
Society of Clinical Research Associates is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.

DISCLOSURE OF RELATIONSHIPS AND DECLARATIONS: CNE AND CME ACCREDITED SOCRA PROGRAMS

SOCRA adheres to the ACCME’s & ANCC’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.

SOCRA program content addresses regulatory issues and clinical research policies and procedures, no commercial therapies are discussed, no commercial (drug/device/biologic) products are discussed, and no commercial support is involved with SOCRA programs.

Planners and Speakers for programs have no undisclosed commercial relationships.

Components visible upon registration.